 | This articleneeds additional citations forverification. Please helpimprove this article byadding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Cilag" – news ·newspapers ·books ·scholar ·JSTOR(December 2008) (Learn how and when to remove this message) |
Cilag AG is a Swisspharmaceutical company. Cilag is a subsidiary of American pharmaceutical giantJohnson & Johnson. The company is part of Johnson & Johnson Innovative Medicine business segment.
In 1933, Swiss chemistBernhard Joos set up a small research laboratory inSchaffhausen, Switzerland. This set the basis for the founding ofChemische Industrie-Labor AG (Chemical Industry Laboratory AG or Cilag) on 12 May 1936.
The first president of Cilag's administrative board was Carl Naegeli, a well-known professor at the Chemical Institute of theUniversity of Zurich. After the death of Naegeli in 1942, Joos himself then took over the managing role until he left the company in 1949.[1]
In 1959, Cilag joined theJohnson & Johnson family of companies.
In the early 1990s, the marketing organizations of Cilag andJanssen Pharmaceuticals were joined to formJanssen-Cilag. The non-marketing activities of both companies still operate under their original name.
Cilag continues to have operations under the Cilag name in Switzerland, ranging from research and development through manufacturing and international services.
In August 2014 Cilag acquiredCovagen a biopharmaceutical company which specialises in the development of multi-specific protein based therapeutics. As part of the acquisition Cilag will gain access to Covagen’s lead drug candidate,COVA 322, a bi-specific anti-tumor necrosis factor (TNF)-alpha/anti-interleukin (IL)-17A FynomAb, is in a Phase Ib study forpsoriasis.[2]
Joos' first discovery waspyridazil, an azo dyestuff derived frompyridine, which is ananalgesic for theurinary tract.[3] By 1952 Joos had discovered seven new chemical compounds and developed them into new products.
The company's research and development record covers discoveries and developments in the fields ofbiotechnology,central nervous system,women's health,dermatology,anti-infectives andimmunology.
{{cite book}}: CS1 maint: others (link)| International | |
|---|---|
| People | |
